✦ LIBER ✦

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

✍ Scribed by Yoshida, Tatsuya; Ishii, Genichiro; Goto, Koichi; Yoh, Kiyotaka; Niho, Seiji; Umemura, Shigeki; Matsumoto, Shingo; Ohmatsu, Hironobu; Nagai, Kanji; Ohe, Yuichiro; Ochiai, Atsushi

Book ID: 125347590
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 843 KB
Volume: 139
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-013-1495-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pretreatment Epidermal Growth Factor Rec

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer

✍ Su, K.-Y.; Chen, H.-Y.; Li, K.-C.; Kuo, M.-L.; Yang, J. C.-H.; Chan, W.-K.; Ho, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 676 KB

Volumetric tumor growth in advanced non-

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Timing of Epidermal Growth Factor Recept

Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations

✍ Moran, T.; Sequist, L. V. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 202 KB

Efficacy of EGFR Tyrosine Kinase Inhibit

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Sandro Barni 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB

Correlation of survival and EGFR mutatio

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients

✍ Yan Sun,Xinmin Yu,Xun Shi,Wei Hong,Jun Zhao… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 384 KB

Disease Flare After EGFR Tyrosine Kinase

Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer

✍ Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, Zhi-Hong Chen… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 214 KB